On Friday, the World Health Organization (WHO) approved two new treatments for the pandemic coronavirus. This new treatment method and other vaccines can prevent severe illness and death due to this virus—news from AFP.
The number of people infected with the Corona Omicron variant is increasing in different world countries. The WHO estimates that half of Europe’s population will be infected with the corona by March.
Experts from the World Health Organization (WHO) in the British Medical Journal (BMJ) say that in patients with severe coronary heart disease, the arthritis drug baricitinib, combined with a drug called corticosteroids, reduces the risk of ventilation. The risk of death is also reduced.
To reduce the risk of coronary heart disease in the elderly, those with a weakened immune system, or diabetes, experts recommend the synthetic antibody treatment StroviMab.
However, those at risk of coronary heart disease are less likely to need Strovimab. The World Health Organization says it is still unclear how effective it will be against new types of the corona, such as Omicron.
The World Health Organization has approved three more treatments for coronavirus. In September 2020, the World Health Organization approved the use of corticosteroids in the treatment of critically ill people infected with the coronavirus. Corticosteroids are cheaper, and it works quickly in cases of serious illness.
In July last year, the World Health Organization approved Tocilizumab and Sarilumab, two other arthritis drugs. However, the newly approved baricitinib is somewhat different from these drugs.
